非洛地平
耐受性
医学
心绞痛
安慰剂
钙通道阻滞剂
药理学
不利影响
心脏病学
内科学
血压
心肌梗塞
替代医学
病理
作者
Kinjal Navadiya,Sanjay Tiwari
出处
期刊:Current Drug Safety
[Bentham Science Publishers]
日期:2015-09-18
卷期号:10 (3): 194-201
被引量:12
标识
DOI:10.2174/1574886310666150514114619
摘要
Calcium channel blockers (CCBs) are a heterogeneous group of drugs often used in the therapy for hypertension and angina. Though CCBs are generally similar in terms of their efficacy yet, they differ in their ability of causing selective inhibition in the contractility of vascular smooth muscle in comparison to cardiac muscle. Felodipine is one of the most vascular selective of the available CCBs and it has no negative inotropic effects at clinically administered doses. Focus of this review is to comprehensively summarize the pharmacokinetics, efficacy, safety and tolerability of felodipine. This review is based on evaluation of relevant literature on felodipine using meta-database PubMed and ScienceDirect and internet search engine (Google Scholar). Clinical studies summarized in this review testify, on technical lines, the clinical efficacy, safety and placebo- like tolerability profile of felodipine, administered alone as well as in combination.
科研通智能强力驱动
Strongly Powered by AbleSci AI